Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada

Hamid Tavakoli1, Kate M Johnson1, J Mark FitzGerald2, Don D Sin3, Andrea S Gershon4, Tetyana Kendzerska5, Mohsen Sadatsafavi1,2 On behalf of the Canadian Respiratory Research Network1Respiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada; 2Institute for Heart and Lung Health, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada; 3Centre for Heart Lung Innovation (the James Hogg Research Centre), St. Paul’s Hospi... Mehr ...

Verfasser: Tavakoli H
Johnson KM
FitzGerald JM
Sin DD
Gershon AS
Kendzerska T
Sadatsafavi M
Dokumenttyp: Artikel
Erscheinungsdatum: 2019
Reihe/Periodikum: International Journal of COPD, Vol Volume 14, Pp 2003-2013 (2019)
Verlag/Hrsg.: Dove Medical Press
Schlagwörter: COPD / Medication / Cost / Trend / SABA / ICS / LABA / LAMA / SAMA / Diseases of the respiratory system / RC705-779
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26861974
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doaj.org/article/ae0a41cfac7f4a10afe8012b5f4a7a56